DJSG
WST icon

D.J. St. Germain’s West Pharmaceutical WST Stock Holding History

D.J. St. Germain’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5K Hold
6
– – ﹤0.01% 831
2025
Q4 		$1.65K Hold
6
– – ﹤0.01% 823
2025
Q3 		$1.57K Hold
6
– – ﹤0.01% 810
2025
Q2 		$1.31K Hold
6
– – ﹤0.01% 809
2025
Q1 		$1.34K Hold
6
– – ﹤0.01% 749
2024
Q4 		$1.97K Hold
6
– – ﹤0.01% 734
2024
Q3 		$1.8K Hold
6
– – ﹤0.01% 681
2024
Q2 		$1.98K Hold
6
– – ﹤0.01% 684
2024
Q1 		$2.37K Hold
6
– – ﹤0.01% 671
2023
Q4 		$2.11K Hold
6
– – ﹤0.01% 683
2023
Q3 		$2.25K Buy
+6
New +$2.32K ﹤0.01% 646

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.J. St. Germain's WST Position: Q1 2026 in Review

D.J. St. Germain held its West Pharmaceutical (WST) position steady in Q1 2026 at 6 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #831.

D.J. St. Germain first reported a position in WST in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.37K in Q1 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • D.J. St. Germain held 6 shares of West Pharmaceutical worth $1.5K as of Q1 2026.
  • D.J. St. Germain left its West Pharmaceutical share count unchanged in Q1 2026.
  • West Pharmaceutical made up ﹤0.01% of D.J. St. Germain's portfolio in Q1 2026, its #831 holding.
  • D.J. St. Germain first reported a position in West Pharmaceutical in Q3 2023 and has held it in 11 quarters since.
  • D.J. St. Germain's West Pharmaceutical position peaked at $2.37K in Q1 2024.
  • 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on D.J. St. Germain's 13F filing for Q1 2026, filed 13 Apr 2026.